If you caught President Biden’s first State of the Union Address last week, you know that bringing drug prices down is at the forefront of his administration’s goals. In that same vein, a recent KIMT3 News article discussed a new non-profit organization that aims to make insulin more accessible for Americans. The company is called Civica Rx, and it was co-rounded by the Mayo Clinic. It plans to manufacture and distribute a variety of insulin products including Glargine, Lispro, and Apsart, which are alternatives for Lantus, Humalog, and Novolog, respectively.
Mayo-Backed Nonprofit to Make Cheaper Insulin
Civica Rx will manufacture the majority of its low-cost insulin products in the United States.
Mar 7, 2022
Recommended
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
